Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» pancreatic cancer
pancreatic cancer
Incyte pancreatic cancer drug improves survival in mid-stage trial
Reuters
Wed, 08/21/13 - 10:18 am
Incyte
pancreatic cancer
Jakafi
Celgene’s Abraxane: A Therapy for Advanced Pancreatic Cancer?
Motley Fool
Mon, 06/10/13 - 10:56 am
Celgene
Abraxane
pancreatic cancer
Novartis
Pfizer
3 Stocks to Watch Ahead of ASCO
Motley Fool
Tue, 05/28/13 - 06:28 pm
cancer
ASCO
nivolumab
Bristol-Myers Squibb
idelalisad
Gilead
PEGPH20
Halozyme
pancreatic cancer
New Pancreatic Cancer Drug an FDA Priority
Motley Fool
Sun, 05/26/13 - 11:20 am
pancreatic cancer
Celgene
Abraxane
Halozyme rises on pancreatic cancer drug study
Yahoo/AP
Thu, 05/16/13 - 05:30 pm
pancreatic cancer
Halozyme
PEGPH20
Diabetes Drugs Are Being Evaluated for Pancreatic Risk
Bloomberg
Thu, 03/14/13 - 11:15 am
pancreatic cancer
diabetes
Merck
Januvia
Bristol-Myers Squibb
Byetta
Novo Nordisk
Victoza
Peregrine's Epic Failure (Maybe)
Motley Fool
Fri, 02/15/13 - 11:42 am
Peregrine Pharmaceuticals
pancreatic cancer
bavituximab
3 Events Biotech Investors Need to Watch in 2013
Motley Fool
Thu, 02/14/13 - 10:28 am
Vical
Allovectin
metastatic melanoma
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Afrezza
diabetes
MannKind
Peregrine Pharma Is Wasting Money On A Placebo Cancer Drug
TheStreet.com
Wed, 02/13/13 - 11:00 am
Peregrine Pharmaceuticals
bavituximab
pancreatic cancer
Celgene’s Abraxane Benefits Pancreatic Cancer Patients
Bloomberg
Wed, 01/23/13 - 10:40 am
Celgene
Abraxane
pancreatic cancer
3 Things to Watch at Merrimack
Motley Fool
Sun, 12/30/12 - 12:12 pm
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
MM-121
breast cancer
lung cancer
Does Merrimack Pharmaceuticals Have A Blockbuster Drug With MM-398?
Seeking Alpha
Thu, 12/6/12 - 05:32 pm
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Abraxane Cancer Trials Help Justify Celgene Buyout
investors.com
Sat, 11/17/12 - 02:03 pm
Abraxane
Celgene
pancreatic cancer
Is Threshold on the Threshold of Something Big?
Motley Fool
Fri, 11/16/12 - 10:34 am
Threshold Pharmaceuticals
TH-302
pancreatic cancer
2 Reasons You Should Love This Biotech's Good News
Motley Fool
Tue, 11/13/12 - 11:12 am
Celgene
pancreatic cancer
Abraxane
Celgene Rises as Abraxane Meets Pancreatic Cancer Goals
Bloomberg
Mon, 11/12/12 - 10:57 am
Celgene
pancreatic cancer
Abraxane
Survey Of The Pancreatic Cancer Drug Market With Celgene's Abraxane In Focus
Seeking Alpha
Sun, 11/11/12 - 09:56 am
pancreatic cancer
Celgene
Abraxane
Abraxane Demonstrates Statistically Significant Improvement in Overall Survival for Patients with Advanced Pancreatic Cancer in Phase III Study
Yahoo/BusinessWire
Sat, 11/10/12 - 08:25 am
Abraxane
pancreatic cancer
Celgene's Abraxane Is Talk of European Cancer Confab
TheStreet.com
Mon, 10/1/12 - 10:39 am
Celgene
Abraxane
pancreatic cancer
Celgene CVR: Upside Into Abraxane Pancreatic Cancer Trial Data
TheStreet.com
Tue, 09/25/12 - 11:37 am
Celgene
Abraxane
pancreatic cancer
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »